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This paper reports the first genomic RNA sequence of a field strain feline
coronavirus (FCoV). Viral RNA was isolated at post mortem from the jejunum
and liver of a cat with feline infectious peritonitis (FIP). A consensus sequence of
the jejunum-derived genomic RNA (FCoV C1Je) was determined from
overlapping cDNA fragments produced by reverse transcriptase polymerase
chain reaction (RT-PCR) amplification. RT-PCR products were sequenced by
a reiterative sequencing strategy and the genomic RNA termini were determined
using a rapid amplification of cDNA ends PCR strategy. The FCoV C1Je genome
was found to be 29,255 nucleotides in length, excluding the poly(A) tail.
Comparison of the FCoV C1Je genomic RNA sequence with that of the
laboratory strain FCoV FIP virus (FIPV) 79-1146 showed that both viruses have
a similar genome organisation and predictions made for the open reading frames
and cis-acting elements of the FIPV 79-1146 genome hold true for FCoV C1Je. In
addition, the sequence of the 30-proximal third of the liver derived genomic RNA
(FCoV C1Li), which encompasses the structural and accessory protein genes of
the virus, was also determined. Comparisons of the enteric (jejunum) and
non-enteric (liver) derived viral RNA sequences revealed 100% nucleotide
identity, a finding that questions the well accepted ‘internal mutation theory’ of
FIPV pathogenicity.
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eline coronavirus (FCoV) infection is ex-
tremely common in cats worldwide. In
the United Kingdom approximately 40%
of the domestic cat population is seropositive
and where cats are housed together in multi-cat
households, this figure increases still further to
around 90% (Addie and Jarrett 1992, Sparkes
et al 1992, Addie 2000). Natural infections with
FCoVare usually transient, although a significant
percentage of infections may become persistent
(Addie and Jarrett 2001). Most infections are
asymptomatic or result in mild, self-limiting gas-
trointestinal disease and in these cases, the caus-
ative agent is known as feline enteric coronavirus
(FECV). In a small percentage of animals
(<5%), however, a fatal multi-systemic, immune-
mediated disease occurs and this is known as
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928-8065; Fax: þ44-117-928-7896. E-mail: c.dye@bristol.ac.uk1098-612X/07/030202+12 $32.00/0  2007 ESFM afeline infectious peritonitis (FIP) (Pedersen
1995). The virus associated with FIP is referred
to as FIP virus (FIPV) and it is proposed that
cats acquire FIPV by mutation of an endogenous
FECV (Poland et al 1996, Vennema et al 1998).
This hypothesis is known as the ‘internal muta-
tion theory’ and is widely accepted. Despite
this, any genetic differences between FECV and
FIPV that can account for their different pathoge-
nicity remain to be identified.
There are two types of FCoV that can be distin-
guished by serology and by sequence analysis.
Type I viruses are most prevalent in the field
and account for approximately 80% of all infec-
tions (Hohdatsu et al 1992, Addie et al 2003).
Type II viruses are less prevalent and are charac-
terised by recombination events that result in the
replacement of the FCoV spike glycoprotein gene
with the equivalent gene of canine enteric
coronavirus (CCoV) (Herrewegh et al 1998).
There is no evidence that either type is more
commonly associated with FIP in natural infectionsnd AAFP. Published by Elsevier Ltd. All rights reserved.
203Genomic RNA sequence of FCoV C1Je(Benetka et al 2004). The majority of research on
FCoV to date has concentrated on the investiga-
tion of type II strains, most notably FIPV 79-
1146, because they replicate well in cell culture
and are, therefore, easy to work with in the labo-
ratory. However, FIPV 79-1146 is unlikely to be
representative of coronavirus strains that are cur-
rently circulating within domestic cat popula-
tions. Firstly, it was isolated in America in 1979
and the geographical and time differences
make it unlikely that this strain would be in cur-
rent circulation in the UK. Secondly, it is a type II
strain, which represent only 10e20% of field iso-
lates (Hohdatsu et al 1992, Benetka et al 2004,
Kummrow et al 2005). Thirdly, and most impor-
tantly, FIPV 79-1146 has been extensively pas-
saged in cell culture, which increases the
likelihood of mutation. We, therefore, felt it im-
portant that more clinically relevant strains
should be investigated and genomic sequencing
of a field strain virus obtained directly from clin-
ical material was the first step in this process.
The ‘internalmutation theory’ states that FIP oc-
curswhen a cat is exposed to variants of FCoV that
have mutated within the host and are able to dis-
seminate from the gut (primary site of infection)
bygaining the ability to replicate efficientlywithin
macrophages (Pedersen 1995, Poland et al 1996,
Vennema et al 1998). This hypothesis has had
many proponents and numerous speculations
regarding the location of mutation(s) that could
result in the alteration of pathogenicity have been
made (Haijema et al 2004, Rottier et al 2005).
It should, however, be noted that the difference
between FCoV infection with and without FIP
disease is believed to be quantitative rather than
absolute (Meli et al 2004, Rottier et al 2005, Kipar
et al 2006). Most authors have concurred that al-
though low-level monocyte-associated viraemia
is found with FECV infection, this virus is mainly
confined to the gut. This is in contrast to the highly
pathogenic FIPV, which disseminates systemi-
cally with high viral titres. Thus, obtaining se-
quence data from enteric and non-enteric FCoVs
found within individual cats with FIP may shed
more light on any genetic differences between
FECVand FIPV.
This paper presents the first genomic RNA se-
quence of a field strain FCoV. Viral RNA (desig-
nated FCoV C1Je) was isolated at post mortem
from the jejunum of a cat with a histopathologi-
cally confirmed diagnosis of FIP. The sequence
was analysed to identify cis-acting elements in-
volved in the replication, transcription and trans-
lation of viral RNA and to identify the structural,non-structural and accessory proteins encoded
by the genomic RNA. A direct comparison has
been made with similar elements in the previ-
ously published genomic RNA of the laboratory
strain FCoV, FIPV 79-1146. Furthermore, the
structural and accessory gene regions of viral
RNA isolated from the liver of the same cat
(FCoV C1Li) were sequenced and the data de-
rived from the enteric (jejunum) and non-enteric
(liver) sources were compared.
Methods
Isolation of viral RNA
A 0.5 cm3 biopsy of jejunum and liver tissue from
a cat with a diagnosis of FIP (confirmed by histo-
pathology) was placed into 2 ml of ‘RNA later’
solution (Ambion, UK) at post mortem. This
was stored at 4C overnight. The ‘RNA later’ so-
lution was then discarded and the tissue stored
at 80C. RNAwas extracted from the tissue bi-
opsies using a MacheryeNagel Nucleospin RNA
II kit (ABgene, UK) according to the manufactur-
er’s instructions. Briefly, tissue biopsies (30 mg)
were added to 500 ml of lysis buffer with 1%
(v/v) 2-mercaptoethanol in a 2-ml tube contain-
ing a stainless steel ball bearing. Samples were
disrupted using a tissue lyser (Qiagen, UK) at
a frequency of 30 revolutions per second for
2e4 min. Using a ‘shredder column’, 350 ml of
the tissue lysate was homogenised and one vol-
ume of 70% ethanol was added before loading
onto an ‘extraction column’. The sample was
incubated with DNAse solution, washed three
times, eluted in 2 60 ml of RNAse-free water
and stored at 80C.
cDNA synthesis and PCR ampliﬁcation of
viral sequences
Sequence data previously generated for the labo-
ratory strain FCoV, FIPV 79-1146, were used to
design primers for conventional reverse tran-
scriptase polymerase chain reaction (RT-PCR)
amplification of short lengths (100e500 bases)
of the field strain RNA. These primers were
chosen in regions that were expected to show se-
quence conservation on the basis of comparative
analysis of published sequences. Subsequently,
sequence data derived from these short PCR
fragments were used to design field strain spe-
cific PCR primers that were used to amplify lon-
ger overlapping fragments spanning the entire
genome (Fig 1).
204 C Dye and SG SiddellFig 1. The positions of the RT and PCR primers used for the amplification of FCoV C1Je are shown in relation to the ge-
nomic RNA. The FCoV C1Je genomic RNA is illustrated in black ( ). Short C1Je PCR fragments amplified using primers
specific for FIPV 79-1146 are shown in blue ( ). The sequence data derived using these initial primers were used to design
C1Je specific primers for amplification of longer fragments. C1Je specific primers used for reverse transcription and PCR are
highlighted in red ( ). PCR products are represented by a thin black line ( ) joining the forward and reverse PCR primers
and are labelled alphabetically from A to I.For small RT-PCR fragments (<3 kb), Super-
script II RNAse H RT (Invitrogen, UK) was
used to reverse transcribe viral RNA. RNA and
5 pmol of reverse primer were incubated at
65C for 5 min and then chilled on ice. The
RNA/primer mix was then added to a 20 ml
reaction containing 15 units of human placental
ribonuclease inhibitor (HPRI), 1 mM deoxyribo-
nucleotide equimolar mix of dATP, dCTP, dGTP
and dTTP (dNTP), 0.01 M Dithiothreitol (DTT),
200 units of RT and 1 first strand buffer. The re-
action was incubated at 42C for 50 min followed
by 94C for 2 min. Samples were immediately
chilled on ice and stored at 20C. PCR amplifi-
cation was undertaken using recombinant Taq
DNA polymerase (Invitrogen, UK) in a 100 ml re-
action containing 2 ml cDNA, 0.25 mM forward
primer, 0.25 mM reverse primer, 0.8 mM dNTP,
5 units of DNA polymerase, 1 PCR buffer and
2 mM MgCl2. Reactions were incubated at 94
C
for 2 min and then amplified using 35 cycles of
94C for 20 s, 50e65C for 20 s and 68C for
1 min per kb of PCR product. Following a final
incubation of 68C for 10 min, the DNA was
stored at 4C.
For larger RT-PCR fragments (>3 kb), a one-
step RT-PCR amplification was undertaken using
a one-step PCR kit for long templates (Invitro-
gen, UK) according to the manufacturer’s in-
structions. Briefly, a 50 ml reaction containing
RNA, 15 pmol forward primer, 15 pmol reverse
primer, 1 ml Superscript II RT/Platinum Taq
HiFi DNA polymerase enzyme mix and 1 reac-
tion buffer was incubated at 50C for 30 min and
94C for 2 min, followed by 35 cycles of 94C for
15 s, 50e65C for 30 s and 68C for 1 min per kbof PCR product. The reaction was held at 72C
for 7 min and then stored at 4C.
PCR products were purified using SigmaSpin
post-reaction purification columns (Sigmae
Aldrich, UK) or, if non-specific products were
present, then gel purification was undertaken
using a Qiagen gel purification kit (Qiagen, UK)
according to the manufacturer’s instructions. An
aliquot of eachpurifiedDNAwas electrophoresed
in 1 TBE buffer at 100 V for 90 min on a 1% aga-
rose/1 TBE gel containing 50 ml/ml ethidium
bromide. DNA stocks were diluted to a final con-
centration of 100e300 ng/ml and stored at20C.
5 0 RACE and 30 RACE
30- and 50 Rapid amplification of cDNA ends
(RACE) strategies were employed for amplifica-
tion of the viral RNA termini. 30 RACEwas under-
taken by reverse transcribing the RNA using
primer 30-RT followed by PCR amplification
with primers F001 and P036 (Table 1). 50 RACE
was undertaken using a Generacer 50 RACE kit
(Invitrogen, UK) according to the manufacturer’s
instructions. Briefly, RNAwas dephosphorylated
using calf intestinal phosphatase, decapped using
tobacco acid pyrophosphatase and ligated to
a generacer RNA oligo using T4 RNA ligase. Phe-
nol:chloroform extraction and ethanol precipita-
tion of the RNA were undertaken between each
step and the RNA was re-suspended in RNAse-
free water. Reverse transcription was undertaken
with Superscript II RNAse H RT (Invitrogen,
UK) using primer F036 and PCR amplification
was done with Taq DNA polymerase (Invitrogen,
UK) using primers P037 and F036 (Table 1).
205Genomic RNA sequence of FCoV C1JeTable 1. RT and PCR primers used for the ampliﬁcation of FCoV C1Je and FCoV C1Li RNA
Primer
name
Use Nucleotide sequence Position on FCoV
C1Je genome
P037 Forward PCR primer
for fragment A
CGACTGGAGCACGAGGACACTGACAT Designed on
generacer RNA
oligo
F036 RT and reverse PCR
primer for fragment A
GTTAACCAAGCGCAATGATACTCCTCTCC 743e771
F034 Forward PCR primer
for fragment B
CTTCCGTCATGTTGCAGGGCTTTGTCGTTA 549e578
F035 RT and reverse PCR
primer for fragment B
ACTGTTTGTTTTGGCCCATGCATTATAGGATTCT 9649e9682
F029 Forward PCR primer
for fragment C
GGGGAAATGTATGGCGGTTATGAAGAT 9503e9529
F030 RT and reverse PCR
primer for fragment C
ACCTGGCGCTGTTTTTACGAAGTC 12,979e13,002
F002 Forward PCR primer
for fragment D
CTTAAAGATTCAGGTGCGGTTGC 12,586e12,608
F003 RT and reverse PCR
primer for fragment D
AGCTTGGATATGGTGTTGTACTTCTCTT 15,848e15,875
F012 Forward PCR primer
for fragment E
CGCCATATTGAAAGAGGTCGTC 15,570e15,591
F016 RT and reverse PCR
primer for fragment E
AAGTCCTTTCACAGCGTTATTAGA 18,877e18,900
F025 Forward PCR primer
for fragment F
CGGCGAGTACGTTGAACAGATTGAC 18,996e19,020
F026 RT and reverse PCR
primer for fragment F
GTATAAGTTTGCACAGTTGTTGGATTTG 22,771e22,798
F021 Forward PCR primer
for fragment G
TGGCTGGCCTTTACTACACATC 22,561e22,582
F022 RT and reverse PCR
primer for fragment G
ACACATACCAAGGCCATTTTACAT 24,598e24,621
C032-F Forward PCR primer
for fragment H
ATGGATTTAATACTATGGCCTCAGCACT 23,719e23,746
C032-RRT and reverse PCR
primer for fragment H
CTACCCAACGCATTAACACAAAGAA 26,580e26,604
F001 Forward PCR primer
for fragment I
TATGCTGAAGGGTTTAAAATGGCTGGTG 26,672e26,699
P036 Reverse PCR primer
for fragment I
TGTTGGAGGGTAATGGGGTTGAA Designed on 30-RT
primer
30-RT RT primer for
30 RACE
TGTTGGAGGGTAATGGGGTTGAA-
TTTTTTTTTTTTTTTTTTTTTTTNN
29,253epoly(A) tailCycle sequencing
Cycle sequencing was undertaken in 10 ml reac-
tions containing 1 BIG DYE Mix v3.1 (Applied
Biosystems, UK), sequencing primer (5 pmol)
and purified PCR product (100 ng). Amplifica-
tion was undertaken in a GeneAmp 2400 ther-
mocycler (Applied Biosystems, UK) using 25
cycles of 96C for 10 s, 50C for 5 s and 60C
for 4 min. Unincorporated dye terminators and
primers were removed by ethanol precipitation
and the products were then analysed bycapillary electrophoresis using an ABI 310 Ge-
netic Analyser (Applied Biosystems, UK).
Sequence analysis
The ‘Seqman’ program in the Lasergene-6 soft-
ware package (DNASTAR Inc, USA) was used
for the alignment of sequence data. Comparison
of predicted FIPV 79-1146 structural and non-
structural proteins with those of FCoV C1Je
and FCoV C1Li were undertaken with the ‘Meg-
align’ program using the Jotun Hein method.
206 C Dye and SG SiddellThe putative ribosomal frameshift element, as
well as putative 50-untranslated region (50-UTR)
and 30-untranslated region (30-UTR) secondary
structure elements, was identified visually. Prote-
ase cleavage sites within the replicase polyprotein
were predicted by alignment with the repli-
case polyproteins of FIPV 79-1146. The Simplot
v3.5.1 program (http://sray.med.som.jhmi.edu/
SCRoftware/Simplot) was used to analyse for
‘identity’ in the aligned S genes and flanking
regions using a window size of 200 nucleotides
and a step size of 20 nucleotides. The ‘identity’
values were calculated using a maximum likeli-
hood probability.
Results
Genomic sequence of FCoV C1Je
Genomic sequence data were generated for viral
RNA derived from the jejunum of a cat with
a histopathologically confirmed diagnosis of
FIP. The viral RNA was designated FCoV C1Je
and the genomic sequence was derived from
nine overlapping PCR products (seven RT-PCR
and two RACE-PCR) (Fig 1). The genomic RNA
sequence of FCoV C1Je comprises 29,255 nucleo-
tides, excluding the 30 poly(A) tail. The genomic
organisation is similar to that of FIPV 79-1146
and the overall nucleotide composition is A,
28.94%; G, 21.11%; U, 32.69% and C, 17.26%.
The sequence has been deposited with the Gen-
Bank database (accession number DQ848678).
5 0-UTR and 30-UTR
The FCoV C1Je 50-UTR comprises 310 nucleo-
tides, one nucleotide less than that of FIPV 79-
1146. Within this region, two putative secondary
structures, the so-called ‘leader transcription-as-
sociated-sequence hairpin (LTH)’ (nts 91e147)
and a second stem loop structure (nts 57e139)
can be predicted (Fig 2), bearing >90% nucleo-
tide identity with similar structures found in
the FIPV 79-1146 genomic RNA. As in FIPV
79-1146, these structures encompass a ‘mini-
open reading frame (ORF)’ of four codons
(nts 116e127) and the leader ‘transcription-associ-
ated-sequence’ (TAS) (nts 93e98), 50-CUAAAC-30,
which is also located adjacent and upstream of
six putative ORFs in the genomic RNA. The
30-UTR of FCoV C1Je contains a putative bulged
stem loop and pseudoknot, again bearing >90%
nucleotide identity with the analogous structures
of FIPV 79-1146 (Fig 3). As in FIPV 79-1146, thesestructures extend into the upstream ORF7b,
which in this isolate, unlike in 79-1146, appears
to be intact (see below).
ORFs and expression products
As expected, analysis of the FCoV C1Je genomic
RNA sequence data reveals the presence of six
ORFs that, by comparison with other coronavi-
ruses, can be deduced to encode the non-structural
and structural proteins of the virus (Siddell et al
2005, Gorbalenya et al 2006). ORF1a (nts
311e12,391) and ORF1b (nts 311e20,390) encode
the non-structural proteins (nsps). As in FIPV 79-
1146, these ORFs overlap by 46 nucleotides and
a typical coronavirus ‘slip-site’, 50-UUUAAAC-
30 (nts 12,355e12,361), is located within the over-
lap. Adjacent and downstream of the ‘slip-site’ is
a putative pseudoknot structure that shares 100%
nucleotide identity with the putative FIPV 79-
1146 pseudoknot. Amino acid comparisons of
the FCoV C1Je nsps with those of FIPV 79-1146
(Table 2) reveal fairly high conservation (>90%).
The ORFs encoding the structural proteins are
ORF S (nts 20,388e24,791), ORF E (nts 25,846e
26,100), ORF M (nts 26,111e26,900) and ORF N
(nts 26,915e28,045) and their predicted transla-
tion products are the spike glycoprotein (S), the
envelope protein (E), the membrane protein (M)
and the nucleocapsid protein (N). Comparative
sequence analysis shows that most of the struc-
tural proteins of FCoV C1Je are very closely re-
lated to those of FIPV 79-1146 with amino acid
identities exceeding 90% (Table 3). However,
this is not the case for the S protein, which shares
only 43.3% amino acid identity between the two
isolates. Since 80e90% of field strain FCoVs are
serotype I (Hohdatsu et al 1992, Benetka et al
2004), the FCoV C1Je isolate is likely to be
a type I virus. The amino acid identity of the
FCoV C1Je S protein with that of published
FCoV type I S protein sequence data is very
high (>85%) (Table 4) confirming that it as
a type I strain. FIPV 79-1146 is a serotype II isolate
and this is illustrated by the finding that the FIPV
79-1146 S protein shares strong (>90%) amino
acid identity with published CCoV isolates
(Table 5). Previous predictions based on limited
sequence data have identified type II FCoV
strains with a double recombination event occur-
ring in the 50 half of ORF1b (Herrewegh et al
1998) and between the S andM genes (Motokawa
et al 1996). The FIPV 79-1146 and FCoV C1Je S
genes and their flanking sequences were aligned
and a graph of the relative nucleotide identities
207Genomic RNA sequence of FCoV C1JeFig 2. Two mutually exclusive stem loop structures (a) and (b) are predicted. The leader TAS element is highlighted in pink
and a four codon ‘mini ORF’ is highlighted in green. Nucleotides that are different from those in the analogous FIPV 79-1146
structures are highlighted in red.
Fig 3. A putative molecular switch is present within the 30-UTR region of the FCoV C1Je genomic RNA consisting of a dou-
ble stem loop structure and a pseudoknot. The nucleotide positions in the FCoV C1Je genome are indicated and nucleotides
differing from those in the analogous structures of FIPV 79-1146 are shown in red. The 30 end of ORF7b is highlighted in blue.
208 C Dye and SG SiddellTable 2. Comparison of predicted FCoV C1Je replicase cleavage products with those of FIPV 79-1146
Cleavage
product
Polyprotein Position in
polyprotein
(amino acid
residues)
Size
(aa)
Expression Amino acid
identity (%)
with FIPV
79-1146
Putative
function
nsp1 pp1a/pp1ab 1Met-Gly110 110 TIþ PLpro 91.8
nsp2 pp1a/pp1ab 111Val-Gly879 769 PLpro 90.5
nsp3 pp1a/pp1ab 880Gly-Gly2397 1518 PLpro 86.9 PLpro(s), ADRP
nsp4 pp1a/pp1ab 2398Ser-Gln2887 490 PLproþ 3CLpro 93.5
nsp5 pp1a/pp1ab 2888Ser-Gln3189 302 3CLpro 96.4 3CLpro
nsp6 pp1a/pp1ab 3190Ser-Gln3483 294 3CLpro 90.5
nsp7 pp1a/pp1ab 3484Ser-Gln3566 83 3CLpro 94.0
nsp8 pp1a/pp1ab 3567Ser-Gln3761 195 3CLpro 96.9
nsp9 pp1a/pp1ab 3762Asn-Gln3872 111 3CLpro 95.5 ssRNA binding
nsp10 pp1a/pp1ab 3873Ala-Gln4007 135 3CLpro 97.0
nsp11 pp1a 4008Gly-Asp4026 19 3CLproþ TT 94.7
nsp12 pp1ab 4008Gly-Gln4937 929 RFSþ 3CLpro 96.8 RdRp
nsp13 pp1ab 4938Ala-Gln5536 599 RFSþ 3CLpro 94.7 Helicase
nsp14 pp1ab 5537Ser-Gln6055 519 RFSþ 3CLpro 95.2 Exonuclease
nsp15 pp1ab 6056Ser-Gln6394 339 RFSþ 3CLpro 95.9 Endoribonuclease
nsp16 pp1ab 6395Ser-Pro6694 300 RFSþ 3CLproþ TT 93.0 20-O-Methyltransferase
nsp¼ non-structural protein, TI¼ translation initiation, TT¼ translation termination, RFS¼ ribosomal frameshift,
PLpro¼ papain-like proteinase, 3CLpro¼ 3C-like proteinase, ADRP¼ADP-ribose 10 phosphatase, RdRp¼ RNA-
dependent RNA polymerase, ssRNA¼ single stranded RNA.was plotted. This was used to make a prediction
for the putative crossover sites of FIPV 79-1146
with CCoV (Fig 4). The upstream crossover site
was predicted to lie at position 20,119e20,200 (30
end of ORF1b) and the downstream crossover
site at position 24,328e24,329 (30 end of S gene)
in the FIPV 79-1146 genome (GenBank accession
number DQ010921). A short conserved region of
approximately 900 nucleotides lying within the
predicted recombination site is likely to represent
the heptad repeat sequences in the S2 subdomainwhich are essential for fusogenic activity and are
conserved throughout coronaviruses (Bosch et al
2003, de Haan and Rottier 2005).
Analysis of the accessory gene 3 cluster of the
FCoV C1Je genome reveals ORFs corresponding
to 3a and 3b as found in the FIPV 79-1146 isolate.
Although the encoded proteins appear to be
analogous to those of FIPV 79-1146 and are of
similar length, the amino acid conservation is
not high (Table 3). This may reflect the fact that
these ORFs are believed to be dispensable forTable 3. Comparison of predicted FCoV C1Je non-structural, structural and accessory proteins with
those of FIPV 79-1146 and FCoV C1Li
ORF (nucleotide positions) Translation product (amino acids) Amino acid identity (%)
FIPV 79-1146 FCoV C1Li
ORF1a (311e12,391) Polyprotein 1a (4026) 90.8 e
ORF1ab (312e20,390) Polyprotein 1ab (6692) 92.7 e
ORF S (20,388e24,791) Spike glycoprotein (1466) 43.3 100
ORF3a (24,803e25,015) Accessory protein 3a (69) 67.1 100
ORF3b (24,963e25,175) Accessory protein 3b (69) 50.0 100
ORF E (25,846e26,100) Small membrane protein (81) 91.5 100
ORF M (26,111e26,902) Membrane protein (262) 94.3 100
ORF N (26,915e28,045) Nucleocapsid protein (376) 91.5 100
ORF7a (28,050e28,355) Accessory protein 7a (100) 94.1 100
ORF7b (28,360e28,980) Accessory protein 7b (206) 91.7 100
209Genomic RNA sequence of FCoV C1Jereplication in cell culture and are thus unlikely to
be conserved in the laboratory-adapted strain of
FIPV 79-1146 (Haijema et al 2004). As in FIPV 79-
1146, ORF3c of FCoV C1Je appears to be defunct
and has a stop codon after only 16 amino acids.
However, the introduction of only two
nucleotide mutations would enable extension of
the reading frame to overlap with that of ORF E
(Fig 5). Analysis of the accessory gene 7 region of
the FCoV C1Je genome identifies two ORFs,
which have translation products sharing high
amino acid identity with proteins 7a and 7b of
FIPV 79-1146. However, unlike the FIPV 79-1146
ORF7b, which appears to terminate early as a re-
sult of a single nucleotide mutation (C28,374 to
U28,374) (Dye and Siddell 2005), the FCoV C1Je
ORF7b is intact.
Comparison of enteric and non-enteric FCoVs
Using the strategy outlined earlier, the sequence
of the 30-proximal 10 kb (nts 19,060e29,255) of
viral RNA derived from liver tissue of the same
cat was determined. This sequence was desig-
nated FCoV C1Li. When the nucleotide and
amino acid sequences of FCoV C1Je (enteric)
and FCoV C1Li (non-enteric) were compared,
the sequences were found to be identical. Thus,
cis-acting RNA elements in this region, as well
Table 4. Direct amino acid comparison of the
FCoV C1Je S protein with the S proteins of pub-
lished FCoV type I isolates
Type I
FCoV strain
GenBank
database ID
S protein
amino acid
identity (%)
Black AB088223 87.1
Ku-2 AAB47503 86.7
UCD-1 AB088222 87.8
NTU2/R AAZ86077 89.3
Table 5. Direct amino acid comparison of the
FIPV 79-1146 S protein with the S proteins of
published CCoV and FCoV type II isolates
Viral
strain
GenBank
database ID
S protein
amino acid
identity (%)
CCoV CCV-6 A22882 91.2
CCoV K378 X77047 91.8
FCoV 79-1146 X06170 99.8
FCoV 79-1683 X80799 95.1as the structural and accessory genes and en-
coded proteins of the two RNAs, were found to
share 100% identity (Table 3).
Discussion
The genomic RNA sequence of FCoV C1Je pro-
vides the first full-length sequence of a field strain
FCoV. Comparisons with the genomic RNA of
FIPV 79-1146 show that as expected it has a very
similar genome organisation and predictions
made for the ORFs and cis-acting elements within
FIPV 79-1146 are equally valid for FCoV C1Je.
However, more detailed comparative sequence
analysis of the field strain type I RNA (FCoV
C1Je) with that of the type II laboratory strain
(FIPV 79-1146) does reveal a number of interest-
ing differences. As expected there was significant
diversity in the S gene region resulting from the
evolutionary recombination of FIPV 79-1146 with
CCoV (Herrewegh et al 1998). The discontinuous
transcription method used by coronaviruses
is very similar to that of the template switching
that occurs during similarity-assisted or high
frequency copy-choice RNA recombination (Sa-
wicki and Sawicki 2005, Sawicki 2005). Recom-
bination is a common phenomenon amongst
coronaviruses (Wang et al 1993, Schaad and Baric
1994, Collisson et al 1995, Rest and Mindell 2003,
Johnson et al 2005) and it may have greater evo-
lutionary significance than the slow process of
Fig 4. The identity of the aligned FIPV 79-1146 and FCoV
C1Je S genes and flanking regions calculated using the ‘Sim-
plot’ program is shown. An identity of 1.0 indicates regions
sharing 100% nucleotide similarity. The positions of ORF1b,
ORF S and ORF3abc are shown and putative sites for recom-
bination of the FIPV 79-1146 S gene with that of CCoVare in-
dicated with red arrows. The identity calculation was
undertaken using a window size of 200 nucleotides and
a step size of 20 nucleotides.
210 C Dye and SG SiddellFig 5. The gene 3 region of FCoV C1Je is shown. ORF3a is highlighted in yellow, ORF3b in turquoise and ORF3c, which
terminates prematurely, is shown in pink. Extension of the degenerate ORF3c to overlap with ORF E (green) would require
only two nucleotide mutations (one change and one deletion) and is illustrated in pale pink.genetic drift. It provides a mechanism for the
rapid formation of new viral strains with dra-
matically altered tropisms and pathogenicity,
which can have a significant impact on host dis-
ease. First, it raises the threat of potentially lethal
phenotypes emerging over a very short evolu-
tionary time scale and second, it compounds
the difficulties of vaccine production resulting
from the heterogeneity of virus populations.
This again emphasises the importance ofinvestigating current field strain viruses rather
than relying solely on laboratory-adapted
isolates.
Second, comparisons of the replicase proteins
of FIPV 79-1146 and FCoV C1Je showed them
to be extremely similar and 15 of the 16 non-
structural proteins had amino acid identities of
>90%. The amino acid identity of the nsp3 re-
gions was, however, slightly lower at 86.9%
and this was largely due to the presence of an
211Genomic RNA sequence of FCoV C1Jeextra 65 amino acids in FCoV C1Je. The closely
related coronavirus Transmissible Gastroenteritis
Virus (TGEV) also contains similar additional
amino acids within its nsp3 region (Penzes et al
2001) and it is most likely that a 65 amino acid
deletion has occurred in FIPV 79-1146 during
its passage in cell culture. The presence of this
deletion in FIPV 79-1146 suggests that this partic-
ular region is not required for viral replication, at
least in vitro.
Analysis of the accessory gene regions of the
clinical strain is particularly interesting. It has
long been suspected that these genes confer a se-
lective advantage in vivo but are not required in
vitro (Herrewegh and Vennema, 1995, Kennedy
et al 2001, Haijema et al 2003), and that analysis
of sequences derived directly from clinical mate-
rial might, therefore, provide some insight into
their importance. Both gene 3 and gene 7 regions
have also been implicated in viral pathogenicity.
For example, mutant viruses containing either
3abc or 7ab cluster deletions multiply well in
cell culture but show an attenuated phenotype
in the cat (Haijema et al 2004). Interestingly,
cats vaccinated with either of these viral mutants
showed some protection against a lethal homolo-
gous challenge but vaccination with a mutant
virus lacking both gene clusters provided no pro-
tection (Haijema et al 2004). It is certainly note-
worthy that ORF7b is intact in the clinical
strain but not in FIPV 79-1146. This region, along
with ORF3c, has been previously implicated in
viral pathogenicity. For example, investigation
of paired FECV/FIPV samples from various geo-
graphical locations has suggested that the FIPV
may arise from deletion mutations in the FECV
accessory genes (Vennema et al 1998). Further in-
vestigation into the function of the encoded 7b
protein would certainly be rewarding. It has pre-
viously been shown that the 3c gene region of
FIPV 79-1146 is degenerate but that it could be
restored by just two nucleotide insertions that
would enable its extension to overlap with ORF
E (Dye and Siddell 2005). It was, therefore, sus-
pected that the ORF3c of FCoV C1Je might be in-
tact, but this was not the case. It is difficult to
speculate on the implications of this finding but
is does at least suggest that the 3c protein may
have restricted functional significance in vivo.
In this paper, viral RNA extracted from two
different tissue samples, one enteric (jejunum)
and one non-enteric (liver), was sequenced
and compared in an attempt to investigate the
possibility of genetic differences that might
account for the enhanced pathogenicity of FIPVcompared with FECV. The finding of a 100% nu-
cleotide identity in the structural and accessory
gene regions of the enteric virus (FCoV C1Je)
and the non-enteric virus (FCoV C1Li) does not
support this view. In fact, it provides a powerful
argument opposing the ‘internal mutation the-
ory’. However, there are some limitations that
may also explain this result. For example, con-
sensus sequencing will mask minority virus pop-
ulations and it is possible that a second viral
isolate is present at low levels within the cat 1 je-
junum sample. One potential model would be
that following immune impairment in cats with
well-progressed FIP disease, pathogenic FIPV is
able to replicate uncontrollably and migrates
back to the gut where viral loads are able to ex-
ceed those of the enteric FECV strains. Secondly,
it is possible that the important determinants of
pathogenicity are located in the proteins encoded
in the replicase gene region. It is certainly con-
ceivable that interaction between proteins of the
replicase complex and cellular proteins could
have critical importance and that alterations in
this interaction could lead to altered pathogenic-
ity. It is known, for example, that significant CD4
and CD8 T cell epitopes are located in the repli-
case proteins of Murine Hepatitis Virus (MHV)
(Stohlman et al 1993) and it is already clear that
some coronavirus non-structural proteins have
profound effects on cellular processes such as
deubiquitination and Adenosine Diphosphate
(ADP)-ribose metabolism (Barretto et al 2005,
Putics et al 2005). The next step would certainly
be to obtain the full genomic RNA sequence of
FCoV C1Li so that the replicase gene regions
can be compared.
There are still many unanswered questions re-
garding the molecular epidemiology of FCoV.
For example, does the FCoV strain within a de-
fined multi-cat population remain conserved
over time or are new strains constantly emerg-
ing? If new strains do emerge, are they the result
of original strain mutation or ‘de novo’ infections
from external sources? Are all coronavirus posi-
tive cats within a household infected with the
same viral strain and are some cats co-infected
with several FCoV strains simultaneously? Is
the FCoV strain present in the gut always a reflec-
tion of the predominant systemic strain, and sim-
ilarly, do cats with FIP excrete pathogenic FIPV
or only FECV? Is there a consistent mutation
associated with pathogenicity? Various authors
have previously addressed many of these ques-
tions (Addie 2000, Addie and Jarrett 2001,
Pedersen 2002). However, only small sections of
212 C Dye and SG Siddellthe viral genome have so far been considered
and interpretation of the findings has proved dif-
ficult. Now that the genomic RNA sequence of
a type I clinical strain has been elucidated it
will be much easier and quicker to sequence
more extensive specific regions from further viral
field strains. It is hoped that this will help to shed
more light on the findings of future epidemiolog-
ical studies and increase their significance.
Lastly, the genomic RNA sequence of FCoV
C1Je provides a solid foundation for the con-
struction of a full-length cDNA copy of a field
strain FCoV. This could be used as the basis for
production of a reverse genetics system, a tool
that would enable us to study FCoV molecular
biology and pathogenesis. Studying a clinical
isolate in such a way is likely to provide more
clinically relevant information than studying
FIPV 79-1146 and would have greater potential
for use in any future attempt to make a live at-
tenuated vaccine.
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